Whatever you've got to say about Google, it can't hear you over the sound of it banking $85m a day in pure profit • The Register
- TECHNOLOGY
- February 5, 2019
New tool outsmarts COVID-19 virus to help vaccine development: Melbourne researchers have developed a tool to monitor mutations that make it difficult to develop coronavirus (COVID-19) vaccines and drugs. Ensuring treatments remain effective as the virus mutates is a huge challenge for researchers. The powerful new tool harnesses genomic and protein information about the virus
READ MOREThe much-anticipated phase 3 trial of the University of Oxford’s coronavirus vaccine has been paused following a suspected adverse reaction in one of its participants. As developing a successful vaccine has been widely touted as a way to end the pandemic, this will feel like a blow for many people desperate to get back to
READ MORE11.09am BST11:09 As of 10am GMT today, more than 27.66 million people had been reported to be infected by coronavirus globally and 897,349 had died, according to a Reuters tally based on statements from health ministries and government officials. 11.05am BST11:05 Hello, this is Haroon Siddique taking over the blog. You can contact me via
READ MOREHere are five things you need to know about the coronavirus pandemic this Wednesday morning. We’ll have another update for you at 18:00 BST. 1. ‘Safe six’ Social gatherings of more than six people are to be banned in England in an effort to curb a steep rise in coronavirus cases. The ban will come
READ MORECSL to manufacture and supply University of Queensland and Oxford University vaccine candidates for Australia Heads of Agreement signed between CSL and the Australian Government to supply 51 million doses of University of Queensland vaccine to Australia, with first doses scheduled for release from mid-2021 following successful clinical trials. Heads of Agreement signed between CSL
READ MOREPresident Vladimir Putin recently announced that a team of Russian scientists had developed a COVID-19 vaccine and that it had been approved for use by the regulators – at least, in Russia. However, the announcement caused consternation among scientists and clinicians in the rest of the world as human trials for the vaccine – nicknamed
READ MORE